News
Geno Announces New Partnership with Sojitz to Accelerate Commercialization of World’s First Plant-Based Nylon-6
Geno partnered with Sojitz Corporation to accelerate large-scale commercialization of plant-based nylon-6, using Geno’s proprietary technology that converts plant-derived sugars into a 100% renewable carbon-based nylon precursor.
BiOM Farms Develops Animal-Free Media to Address Cost Barrier in Cultivated Meat
BiOM Farms is creating animal-free alternatives to fetal bovine serum (FBS) to reduce cost and improve consistency in cultivated meat production. The company is also developing spontaneously immortalized chicken fibroblast cell lines adapted for scalable suspension culture.
DFRN, Operator of Textile Recycling ‘Circlo’, Attracts Seed Investment from Korea Investment Accelerator
DFRN, operator of Circlo, secured seed funding from Korea Investment Accelerator to advance its AI-driven enzymatic PET depolymerization technology that designs ultra-active PETase variants trained on over 120,000 amino acid sequences, enabling low-temperature textile recycling into high-quality TPA with reusable enzymes, reduced operating costs, and improved material recovery efficiency.
Weiming Shiguang 'Veminsyn' Raises Series B+ to Expand AI Platform for Bioactive Materials
Weiming Shiguang 'Veminsyn' has secured tens of millions of yuan in Series B+ financing from Huatai GenScript and Haibang Investment. The funds will be used to strengthen its AI technology platform, broaden applications of bioactive raw materials, and accelerate global business expansion.
Novomore Biotech Raises Over $1.4 million in Angel Funding to Advance Plant Synthetic Biology
Novomore Biotech has secured more than $1.4 million in angel round financing to accelerate research and commercialization efforts in plant synthetic biology. The investment will support development of new applications and strengthen the company’s position in the emerging field.
NIH Launches $87M Standardized Organoid Modeling Center to Advance Alternatives to Animal Testing
The NIH has awarded $87 million over three years to establish the Standardized Organoid Modeling (SOM) Center, the first national hub dedicated to organoid development. The center will use AI, robotics, and diverse human cell sources to create reproducible organoid protocols, addressing current variability across labs.By providing open access SOM Center aims to accelerate preclinical testing and therapeutic development, beginning with models of the liver, lung, heart, and intestine
Kraig Biocraft Labs Completes Dual-Facility Spider Silk Production Cycle
Kraig Biocraft Laboratories has completed its first simultaneous production cycle across two independent rearing centers, validating a multi-facility model for recombinant spider silk manufacturing. By offsetting operations with a staggered two-week schedule, the company achieved continuous output of cocoons and silkworm eggs.
Evonik and AMSilk Expand Partnership to Scale Sustainable Silk Protein Production
Evonik and AMSilk have signed a long-term agreement to manufacture sustainable silk proteins at industrial scale, commissioning a dedicated production line at Evonik’s Slovakian site. The collaboration expands Evonik’s precision biosolutions portfolio.
Industry leaders use Knowledge Hub to explore 836+ Synthetic Biology news
Gain unparalleled insights, and drive your innovation forward.
Let’s shape tomorrow, today!